Annual Shareholders Equity
$145.78 M
-$78.74 M-35.07%
31 December 2023
Summary:
AlloVir annual stockholders equity is currently $145.78 million, with the most recent change of -$78.74 million (-35.07%) on 31 December 2023. During the last 3 years, it has fallen by -$207.28 million (-58.71%). ALVR annual shareholders equity is now -58.71% below its all-time high of $353.06 million, reached on 31 December 2020.ALVR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$121.12 M
+$826.00 K+0.69%
30 September 2024
Summary:
AlloVir quarterly stockholders equity is currently $121.12 million, with the most recent change of +$826.00 thousand (+0.69%) on 30 September 2024. Over the past year, it has dropped by -$74.22 million (-37.99%). ALVR quarterly shareholders equity is now -67.61% below its all-time high of $373.90 million, reached on 30 September 2020.ALVR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALVR Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -35.1% | -38.0% |
3 y3 years | -58.7% | -54.7% |
5 y5 years | +576.1% | - |
ALVR Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -58.7% | at low | -54.7% | +0.7% |
5 y | 5 years | -58.7% | +383.1% | -67.6% | +269.9% |
alltime | all time | -58.7% | +383.1% | -67.6% | +269.9% |
AlloVir Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $121.12 M(+0.7%) |
June 2024 | - | $120.29 M(-0.1%) |
Mar 2024 | - | $120.44 M(-17.4%) |
Dec 2023 | $145.78 M(-35.1%) | $145.78 M(-25.4%) |
Sept 2023 | - | $195.33 M(-14.7%) |
June 2023 | - | $229.11 M(+18.4%) |
Mar 2023 | - | $193.53 M(-13.8%) |
Dec 2022 | $224.52 M | $224.52 M(-11.3%) |
Sept 2022 | - | $253.23 M(+60.1%) |
June 2022 | - | $158.14 M(-17.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $191.68 M(-14.9%) |
Dec 2021 | $225.27 M(-36.2%) | $225.27 M(-15.7%) |
Sept 2021 | - | $267.30 M(-11.6%) |
June 2021 | - | $302.47 M(-8.4%) |
Mar 2021 | - | $330.37 M(-6.4%) |
Dec 2020 | $353.06 M(-785.5%) | $353.06 M(-5.6%) |
Sept 2020 | - | $373.90 M(-624.5%) |
June 2020 | - | -$71.29 M(-163.0%) |
Mar 2020 | - | $113.11 M(-319.6%) |
Dec 2019 | -$51.50 M(+68.2%) | -$51.50 M |
Dec 2018 | -$30.62 M | - |
FAQ
- What is AlloVir annual stockholders equity?
- What is the all time high annual shareholders equity for AlloVir?
- What is AlloVir annual shareholders equity year-on-year change?
- What is AlloVir quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for AlloVir?
- What is AlloVir quarterly shareholders equity year-on-year change?
What is AlloVir annual stockholders equity?
The current annual shareholders equity of ALVR is $145.78 M
What is the all time high annual shareholders equity for AlloVir?
AlloVir all-time high annual stockholders equity is $353.06 M
What is AlloVir annual shareholders equity year-on-year change?
Over the past year, ALVR annual stockholders equity has changed by -$78.74 M (-35.07%)
What is AlloVir quarterly stockholders equity?
The current quarterly shareholders equity of ALVR is $121.12 M
What is the all time high quarterly shareholders equity for AlloVir?
AlloVir all-time high quarterly stockholders equity is $373.90 M
What is AlloVir quarterly shareholders equity year-on-year change?
Over the past year, ALVR quarterly stockholders equity has changed by -$74.22 M (-37.99%)